Skip to main content
. 2020 Aug 26;10(4):e156. doi: 10.1002/ctm2.156

FIGURE 2.

FIGURE 2

Construction of a three‐lncRNA signature for pCR prediction in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. A, A heatmap of the identified three‐lncRNA signature and the corresponding discriminant score. B, Receiver operating characteristic curve (ROC) for the performance of the three‐lncRNA signature in Beijing training cohort. C, The distributions of the discriminant scores between pCRs and <pCRs in Beijing training cohort. **** P < .0001